Drug Type Recombinant polypeptide |
Synonyms- |
Target |
Mechanism GLP-1R modulators(Glucagon-like peptide 1 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | CN | 25 Jul 2024 | |
Obesity | Preclinical | CN | 25 Jul 2024 |